ALZpath, Siemens Healthineers Partner on Blood-Based Alzheimer’s Testing
Licensing agreement will integrate ALZpath's pTau217 antibody into Siemens' Atellica analyzer test menu for IVD Alzheimer's diagnostics.
Licensing agreement will integrate ALZpath's pTau217 antibody into Siemens' Atellica analyzer test menu for IVD Alzheimer's diagnostics.
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
Researchers demonstrate that cfDNA fragmentation patterns can effectively diagnose and stage bladder cancer, potentially reducing reliance on invasive cystoscopies.
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
The rapid PCR test delivers results up to 75% faster than other point-of-care HCV diagnostics, enabling same-day treatment initiation.